Annual banned‐substance review 16 th edition—Analytical approaches in human sports drug testing 2022/2023
Drug Testing and Analysis · 2024
DOI: 10.1002/dta.3602 ↗At a glance
Übersichtsarbeit in Drug Testing and Analysis, 2024. Written by Mario Thevis and 2 co-authors. Institution: Center for Preventive Doping Research - Institute of Biochemistry, German Sport University Cologne, Cologne, Germany. Major MEDLINE topics: Performance-Enhancing Substances, Doping in Sports, Sports. Cited 12 times so far (Crossref); 165 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Federal Ministry of the Interior, Building and Community of the Federal Republic of Germany, Manfred-Donike-Institute for Doping Analysis, Cologne.
Abstract (original language)
In this 16 th edition of the annual banned‐substance review on analytical approaches in human sports drug testing, literature on recent developments in this particular section of global anti‐doping efforts that was published between October 2022 and September 2023 is summarized and discussed. Most recent additions to the continuously growing portfolio of doping control analytical approaches and investigations into analytical challenges in the context of adverse analytical findings are presented, taking into account existing as well as emerging challenges in anti‐doping, with specific focus on substances and methods of doping recognized in the World Anti‐Doping Agency's 2023 Prohibited List. As in previous years, focus is put particularly on new or enhanced analytical options in human doping controls, appreciating the exigence and core mission of anti‐doping and, equally, the conflict arising from the opposingly trending extent of the athlete's exposome and the sensitivity of instruments nowadays commonly available in anti‐doping laboratories.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Center for Preventive Doping Research - Institute of Biochemistry, German Sport University Cologne, Cologne, Germany.
- European Monitoring Center for Emerging Doping Agents, Cologne, Germany.
- Swiss Laboratory for Doping Analyses, University Center of Legal Medicine, Genève and Lausanne, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Epalinges, Switzerland.
ORCID profiles: Mario Thevis
Funding
- Federal Ministry of the Interior, Building and Community of the Federal Republic of Germany
- Manfred-Donike-Institute for Doping Analysis, Cologne
Cite
APA
Thevis, M., Kuuranne, T., & Geyer, H. (2024). Annual banned‐substance review 16 th edition—Analytical approaches in human sports drug testing 2022/2023. Drug Testing and Analysis. https://doi.org/10.1002/dta.3602
Vancouver
Thevis M, Kuuranne T, Geyer H. Annual banned‐substance review 16 th edition—Analytical approaches in human sports drug testing 2022/2023. Drug Testing and Analysis. 2024. doi:10.1002/dta.3602
BibTeX
@article{Thevis2024,
author = {Thevis, Mario and Kuuranne, Tiia and Geyer, Hans},
title = {Annual banned‐substance review 16 th edition—Analytical approaches in human sports drug testing 2022/2023},
journal = {Drug Testing and Analysis},
year = {2024},
doi = {10.1002/dta.3602}
}
EUVIMED